If you're not happy with the results, please do another search.

Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Jessica Bunge, who lost 30 pounds on Ozempic Mike Kimani, an independent trainer who works out of LM Fitness Center in Atwater, says his GLP-1 workouts are particularly data-driven. “The whole ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss, and wellness. Before Naveini Vasikaran started ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible ... results on Monday for its potential Ozempic successor, but for the second ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

More research is needed to understand the effects of Ozempic and other GLP-1 agonists on people with eating disorders, including the potential of the drugs to treat binge eating disorder.

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro) leads to significant reductions in HbA1c levels and body weight among adults with type 1 diabetes (T1D).

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.